Access
To read this story in full you will need to login or make a payment (see right).
News Feature
Nature 439, 524-525 (2 February 2006) | doi:10.1038/439524a; Published online 1 February 2006
Open Innovation Challenges
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
- More Challenges
- Powered by:
nature jobs
Senior Executive- Finance Corporate Office
- Rhydburg Pharmaceuticals
- Selaqui-Dehradun India
Downstream Processing
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
Lyme disease: Uphill Struggle
Alison Abbott1
- Alison Abbott is Nature's senior European correspondent.
Abstract
The first vaccine against Lyme disease was withdrawn because patients distrusted it. Should market forces be allowed to shape the next one, asks Alison Abbott.
The idea that the customer is always right is gospel in most areas of business. Most, you might think, except the business of making drugs and vaccines.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Is it thee or me??autoimmunity in Lyme diseaseNature Medicine News and Views (01 Dec 1999)
Genome sequencing New tricks of tick-borne pathogenNature News and Views (11 Dec 1997)
